530125 — Samrat Pharmachem Cashflow Statement
0.000.00%
Last trade - 00:00
- IN₹1.09bn
- IN₹1.08bn
- IN₹2.82bn
- 32
- 37
- 38
- 24
2020 March 31st | 2021 March 31st | C2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 57.8 | 73.4 | 236 | 225 | 25.2 |
Depreciation | |||||
Non-Cash Items | 9.59 | 12.1 | 5.92 | 10.1 | -6.19 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -85 | -42.1 | -73.1 | -336 | 68.6 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -13.3 | 48.3 | 175 | -94.4 | 94.1 |
Capital Expenditures | -18.4 | -27.3 | -12.8 | -13.6 | -6.67 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -0.792 | -1.95 | 2.13 | -16.5 | 2.61 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -19.2 | -29.2 | -10.6 | -30.1 | -4.06 |
Financing Cash Flow Items | -8.74 | -12.7 | -6.75 | -12.3 | -6.87 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 20 | -18.9 | -19.5 | 96 | -112 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -12.5 | 0.212 | 145 | -28.4 | -21.9 |